Mixed dementia: Epidemiology, diagnosis, and treatment

Journal of the American Geriatrics Society

Volumn 50, Issue 8, 2002, Pages 1431-1438

  Zekry, Dina ^a,b,c   Hauw, Jean Jacques ^b   Gold, Gabriel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hopital de Geriatrie   (Switzerland)

Author keywords

Alzheimer's disease; Mixed dementia; Older; Review; Vascular dementia

Indexed keywords

CHOLINESTERASE INHIBITOR; GALANTAMINE; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; CLINICAL FEATURE; DEMENTIA; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; INCIDENCE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PREVALENCE; REVIEW; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COMORBIDITY; DEMENTIA; DEMENTIA, VASCULAR; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 0036677921     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50367.x     Document Type: Review

References (139)

1. Definition and epidemiology of dementia: A review
2. Epidemiology of vascular dementia
3. Vascular dementia: A contemporary review of epidemiology, diagnosis, prevention and treatment
4. Reevaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia
5. Clinical diagnosis of dementia: A review
6. Pharmacological treatment of dementia: A review
7. Vascular dementia
8. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology
9. Practice parameter: Management of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology
10. Diagnostic challenges in dementia
11. "Mixed dementia": Adequate or antiquated? A critical review
12. Démence sénile mixte
13. Observations on the brains of demented old people
14. Validity of clinical diagnosis in dementia: A prospective clinicopathological study
15. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
16. Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop
17. The Gospel OAK study stage II: The diagnosis of dementia in the community
18. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex and education
19. Prevalence of dementia in older Japanese-American men in Hawaii
20. Prevalence of dementia and probable senile dementia of Alzheimer type in the Framingham study
21. Prevalence of clinically diagnosed Alzheimer disease and other dementing disorders: A door-to-door survey in Appignano, Macerata Province, Italy
22. The prevalence of dementia as measured by the Cambridge mental disorders of the elderly examination
23. An epidemiological study of dementia in a rural population of elderly women
24. Prevalence of very mild to severe dementia in Denmark
25. Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, Spain
26. Lessons from mixed dementia
27. Non-Alzheimer dementias
28. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
29. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly
30. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease
31. The prevalence of dementia: A quantitative integration of the literature
32. The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies
33. Prevalence and types of dementia in the very old: Results from the Canadian Study of Health and Aging
34. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington State
35. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study
36. A population-based study of dementia in 85-year-olds
37. Dementia.i Age-dependent incidence, prevalence, and mortality in the old old
38. Prevalence of dementia in a Japanese elderly population
39. The clinical issues of age-related dementia
40. The prevalence of dementia and Alzheimer's disease in Shangai, China: Impact of age, gender, and education
41. Prevalence and incidence of senile and multi-infarct dementia in the Lundby study: A comparison between the time periods 1947-1957 and 1957-1972
42. Prevalence of severe dementia in Finland
43. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
44. The role of cerebral ischemia in Alzheimer's disease
45. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales
46. Neuropathology of organic brain syndromes associated with aging
47. Specificity of the clinical diagnosis of dementia
48. Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics
49. Accuracy of clinical diagnosis in primary degenerative dementia: Correlation with neuropathological findings
50. Survival in Alzheimer's disease and vascular dementia
51. Cerebral amyloid angiopathy in dementia and old age
52. The brain diseases causing senile dementia
53. Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis
54. A clinical and autopsy study of dementia in Olmsted Country, Minnesota, 1980-1981
55. The clinical diagnosis of Alzheimer's disease
56. Frequency of Alzheimer's disease in a post-mortem study of psychiatric patients
57. Accuracy of the clinical diagnosis of vascular dementia: A prospective clinical and post-mortem neuropathological study
58. Diagnosing dementia: Do we get it right?
59. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
60. Validation of clinical diagnostic criteria for Alzheimer's disease
61. Diagnosis of dementia: Clinicopathologic correlations
62. Clinicopathological analysis of dementia disorders in the elderly
63. The Consortium to Establish a Registry for Alzheimer's disease (CERAD) II. Standardization of the neuropathologic assessment of Alzheimer's disease
64. The St. George's dementia bed investigation study: A comparison of clinical and pathological diagnosis
65. Clinically diagnosed Alzheimer disease: Neuropathologic findings in 650 cases
66. Pathology and pathophysiology of cerebrovascular dementia: Pure subgroups of obstructive and hypoperfusive etiology
67. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: Retrospective clinicopathological evaluation of a 10-year autopsy population
68. Neuropathological diagnosis in elderly parients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions
69. Multicenter clinicopathological correlation in dementia
70. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study
71. Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease
72. Absence of vascular dementia in an autopsy series from a dementia clinic
73. Immediate causes of death of demented and non-demented elderly
74. A population-based study on the incidence of dementia disorders between 85 and 88 years of age
75. Very old women at highest risk of dementia and Alzheimer disease: Incidence data from the Kungsholmen project, Stockholm
76. Risk factors for Alzheimer's disease: Overview of the EURODEM collaborative re-analysis of case-control studies
77. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective
78. Risk factors for vascular dementia: A review
79. Status of risk factors for dementia associated with stroke
80. Epidemiology of vascular and Alzheimer's dementia among African Americans in Chicago, IL
81. Binswanger's disease: A review
82. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment
83. Aetiological considerations and risk factors for multi-infarct dementia
84. 15-Year longitudinal study of blood pressure and dementia
85. Status of risk factors for vascular dementia
86. The interaction between vascular disorders and Alzheimer's disease
87. The Canadian study of health and aging - Risk factors for vascular dementia
88. Prevalence and etiology of dementia in a Japanese community
89. Urinary and gait disturbances as markers for early multi-infarct dementia
90. Cerebrovascular disease in dementia: The importance of atrial fibrillation
91. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
92. Vascular factors and Alzheimer disease
93. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective
94. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia
95. The diagnosis of "mixed dementia" in the consortium for the investigation of vascular impairment of cognition (CIVIC)
96. A nine word dementia version of the California Verbal Learning Test
97. Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia
98. Perseverative behavior in Alzheimer's disease and subcortical ischemic vascular dementia
99. Neuropsychological aspects of vascular dementia
100. Neuropsychological deficits in vascular dementia vs Alzheimer's disease: Frontal lobe deficits prominent in vascular dementia
101. Differentiation of vascular dementia from AD on neuropsychological tests
102. A double dissociation between accuracy and time of execution on attentional tasks in Alzheimer's disease and multi-infarct dementia
103. Differentiation of vascular demenria from AD on neuropsychological tests
104. Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia
105. Cerebral blood flow in dementia
106. Diagnostic evaluation of degenerative and vascular dementia
107. Sensitivity and specificity of newly proposed criteria for the diagnosis of possible vascular dementia
108. A clinicopathological validation study of four sets of clinical criteria for vascular dementia
109. Meta-analysis of the Hachinski ischemic score in pathologically verified dementias
110. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: A clinicopathological study
111. Clinical and instrumental diagnosis of Alzheimer's disease and multi-infarct dementia
112. Neuroimaging for differentiating vascular from Alzheimer's dementias
113. Computed tomography in the detection of the vascular component in dementia
114. CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia
115. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging
116. White matter changes in dementia of Alzheimer's type
117. The prevalence of white matter lesions on computed tomography of the brain in demented and nondemented 85-year olds
118. Contribution in the diagnosis of Alzheumer's disease and other dementias
119. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study
120. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease
121. Vascular mechanisms in hypertensive cerebrovascular disease
122. Cognitive performance correlates with cerebrovascular impairments in multi-infarct dementia
123. Cognitive performance after small strokes correlates with ischemia not atrophy of the brain
124. Cognitive declines correlated with decreased cortical volume and perfusion in dementia of Alzheimer's type
125. Positron emission tomography in the differential diagnosis of organic dementias
126. Comparison of PET, MRI and CT with pathology in a proven case of Alzheimer's disease
127. Dominantly inherited Alzheimer's disease: Cerebral glucose metabolism
128. Neuroimaging in dementia
129. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome
130. Preventable senility: A call for action against the vascular dementias
131. Improved cognition after control of risk factors for multi-infarct dementia
132. Modeling of risk factors for ischemic stroke: The Willis Lecture
133. Antihypertensive drugs in very old people: A subgroup meta-analysis of randomized controlled trials
134. An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors
135. Galantamine shows efficacy in patients with Alzheimer's disease with cerebrovascular components or probable vascular dementia
136. Galantamine improves cognitive and global abilities in Alzheimer's disease with cerebrovascular components and probable vascular dementia: Preliminary results